Suppr超能文献

来自大自然的生物增强剂及其在现代医学中的适用性。

Bioenhancers from mother nature and their applicability in modern medicine.

作者信息

Randhawa Gurpreet Kaur, Kullar Jagdev Singh

机构信息

Department of Pharmacology, Government Medical College, Amritsar, India.

出版信息

Int J Appl Basic Med Res. 2011 Jan;1(1):5-10. doi: 10.4103/2229-516X.81972.

Abstract

Concept of bioenhancers or biopotentiators was first time reported in 1929 by Bose. A bioenhancer is an agent capable of enhancing bioavailability and efficacy of a drug with which it is co-administered, without any pharmacological activity of its own at therapeutic dose used. Development and consequent isolation of these molecules, such as piperine and quercetin, is considered as scientific breakthrough. A fixed drug combination (Risorine) of rifampicin, isoniazid, and piperine is the result of this research. It contains almost 60% less dose of rifampicin because of its increased bioavailability and it also prevents resistance. This concept is mentioned as yogvahi in ayurveda and was used to increase the effect of medicines by increasing oral bioavailability, decreasing adverse effects and to circumvent parenteral routes of drug administration. More such useful and economically viable drug combinations can be developed by integrating knowledge of time tested ayurveda with modern methods of research. This review is an account of these bioenhancers, available from the natural resources.

摘要

生物增强剂或生物增效剂的概念最早于1929年由博斯报道。生物增强剂是一种能够提高与其共同给药的药物的生物利用度和疗效的物质,在所用治疗剂量下其自身没有任何药理活性。这些分子(如胡椒碱和槲皮素)的开发及随后的分离被认为是科学突破。利福平、异烟肼和胡椒碱的固定药物组合(力速清)就是这项研究的成果。由于其生物利用度提高,它所含的利福平剂量几乎减少了60%,而且还能预防耐药性。这一概念在阿育吠陀中被称为“瑜伽瓦希”,用于通过提高口服生物利用度、减少不良反应以及避免药物的非肠道给药途径来增强药物效果。通过将经过时间考验的阿育吠陀知识与现代研究方法相结合,可以开发出更多这样有用且经济可行的药物组合。这篇综述介绍了这些可从自然资源中获得的生物增强剂。

相似文献

1
Bioenhancers from mother nature and their applicability in modern medicine.
Int J Appl Basic Med Res. 2011 Jan;1(1):5-10. doi: 10.4103/2229-516X.81972.
2
Role of herbal bioactives as a potential bioavailability enhancer for Active Pharmaceutical Ingredients.
Fitoterapia. 2014 Sep;97:1-14. doi: 10.1016/j.fitote.2014.05.005. Epub 2014 May 23.
3
Bioenhancers: Revolutionary concept to market.
J Ayurveda Integr Med. 2010 Apr;1(2):96-9. doi: 10.4103/0975-9476.65073.
5
Empowering the Battle: Bioenhancers as Allies Against Cancer Drug Resistance.
Curr Pharm Biotechnol. 2024;25(12):1552-1563. doi: 10.2174/0113892010192038231107051715.
9
Plant based Bioavailability Enhancers.
Curr Pharm Des. 2022;28(8):642-654. doi: 10.2174/1381612828666220112141355.
10
Natural Bioenhancers in Drug Delivery: An Overview.
P R Health Sci J. 2018 Mar;37(1):12-18.

引用本文的文献

1
Empowering the Battle: Bioenhancers as Allies Against Cancer Drug Resistance.
Curr Pharm Biotechnol. 2024;25(12):1552-1563. doi: 10.2174/0113892010192038231107051715.
2
Research progress on the therapeutic effects of nanoparticles loaded with drugs against atherosclerosis.
Cardiovasc Drugs Ther. 2024 Oct;38(5):977-997. doi: 10.1007/s10557-023-07461-0. Epub 2023 May 13.
4
Therapeutic Values of Earthworm Species Extract from Azad Kashmir as Anticoagulant, Antibacterial, and Antioxidant Agents.
Can J Infect Dis Med Microbiol. 2022 Feb 7;2022:6949117. doi: 10.1155/2022/6949117. eCollection 2022.
5
Co-Delivery of Curcumin and Bioperine via PLGA Nanoparticles to Prevent Atherosclerotic Foam Cell Formation.
Pharmaceutics. 2021 Sep 8;13(9):1420. doi: 10.3390/pharmaceutics13091420.
6
Use of Natural Products in Leishmaniasis Chemotherapy: An Overview.
Front Chem. 2020 Nov 23;8:579891. doi: 10.3389/fchem.2020.579891. eCollection 2020.
7
Effect of rifampin with bio-enhancer in the treatment of newly diagnosed sputum positive pulmonary tuberculosis patients: A double-center study.
J Clin Tuberc Other Mycobact Dis. 2018 Jul 26;12:73-77. doi: 10.1016/j.jctube.2018.07.002. eCollection 2018 Aug.
8
Clinical trials and healthcare needs in India: A difficult balancing act but opportunities abound!
Perspect Clin Res. 2017 Oct-Dec;8(4):159-161. doi: 10.4103/picr.PICR_128_17.
10
Anticancer Potential of Nutraceutical Formulations in MNU-induced Mammary Cancer in Sprague Dawley Rats.
Pharmacogn Mag. 2017 Jan-Mar;13(49):46-50. doi: 10.4103/0973-1296.197652.

本文引用的文献

1
Bioenhancers: Revolutionary concept to market.
J Ayurveda Integr Med. 2010 Apr;1(2):96-9. doi: 10.4103/0975-9476.65073.
2
Cow urine distillate as bioenhancer.
J Ayurveda Integr Med. 2010 Oct;1(4):240-1. doi: 10.4103/0975-9476.74089.
4
Studies on effect of piperine on oral bioavailability of ampicillin and norfloxacin.
Afr J Tradit Complement Altern Med. 2008 Apr 10;5(3):257-62. doi: 10.4314/ajtcam.v5i3.31281.
6
Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors.
Bioorg Med Chem. 2008 Nov 15;16(22):9847-57. doi: 10.1016/j.bmc.2008.09.042. Epub 2008 Sep 19.
7
Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus.
J Antimicrob Chemother. 2008 Jun;61(6):1270-6. doi: 10.1093/jac/dkn088. Epub 2008 Mar 10.
10
Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats.
Int J Pharm. 2007 Jun 7;337(1-2):188-93. doi: 10.1016/j.ijpharm.2007.01.002. Epub 2007 Jan 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验